Featured Research

from universities, journals, and other organizations

Recent methamphetamine use among young men who have sex with men associated with increased risk of sexual practices that may expose them to HIV

Date:
August 1, 2011
Source:
JAMA and Archives Journals
Summary:
Adolescent boys and young men who have sex with men and use methamphetamines appear to be at an increased risk for human immunodeficiency virus (HIV) exposure, according to a new study.

Adolescent boys and young men who have sex with men and use methamphetamines appear to be at an increased risk for human immunodeficiency virus (HIV) exposure, according to a report in the August issue of Archives of Pediatrics and Adolescent Medicine, one of the JAMA/Archives journals.

Among adult men who have sex with men (MSM), methamphetamine use has an estimated prevalence of 43 percent and an association with HIV risk and infection. "Research focuses on older MSM, and little is known about methamphetamine use and sexual behavior among younger MSM (YMSM)," write the authors. They add that the most recent data in this population date back more than 15 years: "Behavior, mortality, and treatment have changed dramatically in 15 years."

Peter Freeman, M.P.H., from Children's Memorial Hospital, Chicago, and colleagues conducted a cross-sectional observational analysis of data from the Adolescent Trials Network for HIV/AIDS Interventions. Between January 2005 and August 2006, a total of 595 adolescent boys and young men ages 12 years to 24 years -- all of whom reported having sex with men -- were recruited from social venues in eight U.S. cities. The study participants completed a survey that included questions about methamphetamine use, other hard drug use and sexual risk behavior.

Of the 595 participants, 64 reported they had used methamphetamines in the last 90 days. The YMSM in this group were more likely than those who had not used hard drugs to have a history of sexually transmitted diseases (51.6 percent vs. 21.1 percent), two or more sex partners in the past 90 days (85.7 percent vs. 63.1 percent), sex with an injection drug user ([IDU]; 51.6 percent vs. 10.7 percent) and sex with someone who has HIV (32.8 percent vs. 11.1 percent). These participants were also less likely to use condoms during every sexual encounter (33.3 percent vs. 54.3 percent). Recent methamphetamine use was associated with a lower likelihood of current school attendance and a history of homelessness, compared with YMSM who reported no recent hard drug use.

"Adolescent boys and young men who have sex with men and use methamphetamine seem to be at high risk for human immunodeficiency virus," conclude the authors. "The findings of our study suggest that there is a need to develop substance abuse prevention and treatment programs as part of HIV prevention for YMSM." They add, "To be most effective among YMSM who use methamphetamine, prevention programs should address issues such as housing, polydrug use, and educational needs. ... Prevention efforts targeting YMSM who use methamphetamine should also ensure that partner selection is addressed, as they showed higher rates of having sex with IDUs and individuals with HIV."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. P. Freeman, B. C. Walker, D. R. Harris, R. Garofalo, N. Willard, J. M. Ellen. Methamphetamine Use and Risk for HIV Among Young Men Who Have Sex With Men in 8 US Cities. Archives of Pediatrics and Adolescent Medicine, 2011; 165 (8): 736 DOI: 10.1001/archpediatrics.2011.118

Cite This Page:

JAMA and Archives Journals. "Recent methamphetamine use among young men who have sex with men associated with increased risk of sexual practices that may expose them to HIV." ScienceDaily. ScienceDaily, 1 August 2011. <www.sciencedaily.com/releases/2011/08/110801173018.htm>.
JAMA and Archives Journals. (2011, August 1). Recent methamphetamine use among young men who have sex with men associated with increased risk of sexual practices that may expose them to HIV. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/08/110801173018.htm
JAMA and Archives Journals. "Recent methamphetamine use among young men who have sex with men associated with increased risk of sexual practices that may expose them to HIV." ScienceDaily. www.sciencedaily.com/releases/2011/08/110801173018.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins